Historically, arterial wall imaging (AWI) has been used in adults to detect vessel wall pathology, including aortic inflammation, in conditions like Takayasu arteritis. 12 Wall enhancement
A rteriopathy is a leading cause of arterial ischemic stroke (AIS) in children and is a predictor of stroke recurrence. 1, 2 Transient cerebral arteriopathy (TCA), intracranial arterial dissection (IAD), primary angiitis of the central nervous system, and moyamoya (MM) are the arteriopathies commonly associated with AIS in children. 3 Attempts have been made to classify pediatric arteriopathies as the etiologic mechanisms; management approaches and prognosis differ. 4, 5 Typically, these arteriopathy subtypes of childhood affect the region of the intracranial carotid bifurcation (distal internal carotid artery, proximal middle cerebral artery, and proximal anterior cerebral artery) making it exceedingly difficult to distinguish the arteriopathy subtypes at presentation. Tan et al 6 demonstrated that magnetic resonance angiography (MRA) may miss cerebral catheter angiography confirmed IAD in ≤50% of cases, and Dlamini et al 7 reported 4 cases of autopsy-confirmed IAD, which mimicked TCA on cerebral catheter angiography. Forty percent of cases of unilateral MM progress to bilateral MM over time. However, at presentation, these cases may be indistinguishable from TCA or IADparticularly in the absence of hypertrophied basal ganglia perforators. 8, 9 Because of the overlapping radiological features of these arteriopathies at presentation, they may be included under the umbrella term of focal cerebral arteriopathy. 10 Cerebral catheter angiography is a luminal technique and is considered the gold standard for detecting arterial pathology. However, it is invasive, requires ionizing radiation-which is a concern in children-and is not widely available. Hence, diagnostic uncertainties at presentation remain a barrier to accurate acute management and adequate patient selection for future clinical trials in children with AIS.
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has been documented on magnetic resonance imaging (MRI) and interpreted as a sign of inflammation in extracranial vessels in giant-cell arteritis. 13 Modification of AWI and the use of high-resolution 3-Tesla contrast-enhanced MRI has been used to diagnose intracranial arterial wall abnormalities and guide management in adults with AIS. [14] [15] [16] [17] [18] A recently published study by Stence et al 19 demonstrated a potential role for AWI in identifying children with AIS who may likely develop progressive arterial disease. Nevertheless, there is a paucity of literature on the diagnostic utility of AWI and its association with distinct pathogeneses of pediatric AIS. 20, 21 The purpose of this study was to investigate the diagnostic utility of AWI in distinguishing across the arteriopathy subtypes and evaluate AWI abnormalities and associated clinical and radiological patterns in a consecutive cohort of children presenting with AIS.
Patients and Methods
The data that support the findings of this study are available from the corresponding author (N.D.) on reasonable request. AWI was conducted in a consecutive cohort of children between January 1, 2010, and December 31, 2015, after adaptation of an adult AWI protocol by study neuroradiologist (M.S.). 18 Children between 1 month and 18 years of age presenting with acute AIS were considered for AWI. AIS was defined as a focal neurological deficit with acute ischemic lesion on MRI in the corresponding vascular territory. AIS and arteriopathy subtype were determined on application of standardized definitions and clinicoradiological consensus. 22 Follow-up AWI scans were reviewed if available. Ethical permission was obtained from the institutional research ethics board, and written informed consent was obtained from all study participants.
AWI Imaging Protocol
AWI was performed on a 3T-Tesla Magnetic Resonance Scanner (Achieva; Philips Medical Systems, Best, the Netherlands) using a 32-channel multitransit head coil. Routine clinical sequences were performed consisting of axial T2-fluid-attenuated inversion recovery, sagittal 3-dimensional T1, axial diffusion-weighted imaging, and time-of-flight MRA. After this, AWI was performed, which included acquisition of high-resolution 2-dimensional TI-fluid-attenuated inversion recovery fast-spin echo sequences (TR/TE/TI, 2158/20/1116 ms; flip angle, 90°; field of view, 19 cm; acquisition matrix, 272×210; 2-mm slice thickness with 1-mm overlap; sensitivity encoding factor, 2; number of averages, 1; SPIR fat saturation; acquisition time per sequence, 3-5 minutes) before and after intravenous administration of gadolinium (Magnevist, gadopentetate dimeglumine). AWI added 10 to 30 minutes to the total scan time. The vessel of interest (VOI) was determined after discussion between the study pediatric neuroradiologist (M.S.) and study neurologists (N.D., M.M., G.d.V., D.M., R.A.) by location of focal brain infarct(s) and abnormality on time-of-flight MRA. In case of no abnormality on the time-of-flight MRA, AWI was focused on the major artery supplying the vascular territory of the acute ischemic lesion. The planes of acquisition for AWI at the VOI were selected by the study pediatric neuroradiologist (M.S.) in a minimum of 2 orthogonal planes, with the number of slices adjusted to cover the VOI. Gadolinium was injected manually using a dose of 0.2 mL/kg as an intravenous bolus, followed by a saline chaser.
Image Analysis
All imaging was reviewed by a pediatric neuroradiologist (P.M.) blinded to the patient clinical information and diagnosis. Imaging review included parenchymal brain abnormality on diffusion-weighted imaging and T2-fluid-attenuated inversion recovery images, vessel involvement on time-of-flight MRA, and vessel wall abnormality on high-resolution AWI images. Precontrast high-resolution T1-weighted AWI images in the region of interest were evaluated for wall thickening, intraluminal signal change suggestive of thrombus, and intramural blood products (native T1 shortening within the vessel wall). Postcontrast high-resolution T1-weighted AWI images were reviewed for presence and patterns of enhancement in region of interest as follows: (1) concentric enhancement defined as continuous circumferential enhancement with the width of the thinnest enhancement being ≥50% of the thickest segment and (2) eccentric enhancement defined as either clearly limited to 1 side of the vessel wall or the thinnest part of the wall enhancement being <50% of the thickest point. Image quality (of the VOI) for each sequence was subjectively assessed as follows: (1) good image quality for interpretation, (2) artifact(s) at VOI, but still adequate for interpretation, and (3) artifact(s) at VOI inadequate for interpretation.
Statistical Analysis
Continuous variables were presented as mean±SD or median and interquartile ranges (IQRs). Qualitative variables were described using frequency distributions. Comparison between groups was conducted using χ 2 /Fisher test for categorical data and Mann-Whitney U test for continuous data. P<0.05 was regarded as significant. Analysis was conducted using SAS University Edition (SAS Institute, Inc, Cary, NC).
Results

Group Description
Twenty-six patients (16 males; median age, 6.4 years [IQR, 3-11.5]) had a total of 47 AWI studies (median time to first AWI, 20 days [IQR, 4-56] after stroke presentation) performed during the study period ( Figure 1 ; Table 1 ). Seventeen of the 47 AWI studies were performed under general anesthesia. Twenty-one patients (81%) presented with focal motor deficits, 5 (19%) with seizures, 1 (4%) with both focal motor deficit and seizures, 4 (15%) with headache, 2 (8%) with ataxia, and 2 (8%) with fever. All patients had ischemic infarction on brain MRI. Eighteen (69%) patients had an abnormal MRA. All children received antithrombotic treatment after diagnosis. Pediatric stroke outcome measure summary scores were obtained in 25 of 26 (96%) children (Table 1) .
AWI Characteristics
Initial AWI Studies
Of 26 patients, 9 (35%) had AWI enhancement of the VOI on their first study. Detailed description of patients presenting with AWI enhancement is reported in Table 2 . AWI enhancement was associated with anterior circulation MRA abnormality (6 internal carotid arteries and 2 middle cerebral arteries) and cortical infarction in 8 of 9 (89%) versus 1 of 9 (11%) with posterior circulation (basilar artery) enhancement, normal MRA, and subcortical (pontine) infarction. Patterns of enhancement were described as concentric or eccentric and associated with the following AIS diagnoses: concentric ( 
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an abnormal MRA. Underlying stroke pathogeneses for this group included TCA (n=5), vasculitis (n=1), MM (n=2), presumed IAD (n=3), cardioembolic (n=1), idiopathic (n=3), perinatal stroke (n=1), and microangiopathic hemolytic syndrome (n=1).
Comparison of the clinical and radiological characteristics of the enhancing versus nonenhancing AWI groups are summarized in Table 1 . No significant differences were found between the 2 groups. However, there was a trend toward statistical significance in age with patients in the enhancing group being of older age (median age, 11.5 versus 6 years; P=0.186). In addition, although nonsignificant, MRA findings were more likely to be abnormal and pediatric stroke outcome measure summary scores higher (1.5: moderate deficit, decreased function versus 0.5: mild deficit, normal function) in those with AWI enhancement. 23 Five children were treated with steroids before their AWI study, 2 of whom had AWI enhancement and 3 of whom had no AWI enhancement with a median time of 46 and 76 days between steroid therapy initiation and the conduct of AWI studies, respectively ( Table 1 ). None of the 26 patients had a recurrent stroke throughout the study period.
Follow-Up Studies
Thirteen patients (median age, 7 years [IQR, 6-11.2]) had 20 follow-up AWI studies (median time from first AWI study to the first follow-up study, 91 days [IQR, 49-93]; Figure 1 ). Four (of 13) had AWI enhancement on their first AWI study, of whom 3 (2 TCA and 1 presumed drug-induced vasospasm) had persistent AWI enhancement on their follow-up studies. One of the 9 patients with negative AWI enhancement on their first AWI study had positive AWI enhancement on their follow-up study in the VOI corresponding to pseudoaneurysm formation ( Figure 2 ). The degree of enhancement in follow-up AWI studies was reduced when compared with earlier studies with positive enhancement (Figures 3 and 4) .
Discussion
This study aimed to explore the associated clinical characteristics and diagnostic utility of AWI enhancement in children with acute AIS. We found that 35% of children with acute AIS had abnormal MRA and demonstrable AWI enhancement in the VOI. In these children, pre-and postcontrast AWI revealed useful adjunctive information with regard to the pathogenesis of the vascular abnormalities. Patterns of AWI enhancement were mostly concentric, and less so, eccentric, which is dissimilar to the findings in adult studies, but concordant with the lack of atherosclerotic plaques found as a cause of AIS in children. Concentric patterns were associated with TCA, vasculitis, vasospasm, and idiopathic AIS, which is comparable with previous reports. 18, 24, 25 Wang et al 26 reported concentric AWI enhancement in a case with MM thought to represent an active angiogenic and inflammatory process within the moyamoya vessels. However, this finding was not replicated in our patients with MM. Patterns of enhancement for patients with cardioembolic stroke in our study were either concentric or eccentric. Only 1 previous study described arterial wall thickening in patients with cardioembolic stroke, which was concentric. 27 The observation of positive eccentric enhancement at the time of development of a pseudoaneurysm 191 days from the time of vertebral artery dissection and the incident stroke in patient 3 was of interest. A few studies have found AWI to be useful to characterize the dynamic changes seen within aneurysms, particularly to predict the future risk of rupture of inflammatory aneurysms and to target treatment of subarachnoid hemorrhage in the presence of multiple unruptured aneurysms. 28, 29 However, AWI remained negative in all other (initially negative) follow-up studies suggesting no additional benefit in conducting the AWI studies in the absence of a clinical indication.
The intensity of enhancement lessened over time in all of the children with follow-up studies. In the study by Stence et al, 19 strong AWI enhancement at onset was associated with progressive arterial disease and AWI abnormalities resolved in the majority (3 of 4; 75%) of those who received corticosteroid therapy. In our study, 3 of 5 (60%) patients who received corticosteroid treatment before AWI did not demonstrate any enhancement on their AWI studies; however, we did not explore the association between intensity of enhancement and progression of arterial disease in those with enhancement. In addition, it remains unclear whether there are temporal correlations between the effects of corticosteroid treatment on inflammation and AWI findings. One study found that the sensitivity of AWI in detecting inflammatory changes in patients with giant-cell arteritis was significantly reduced if patients had received steroid therapy only 2 days before imaging. 30 Hence, the potential role for corticosteroid therapy in preventing progression of arterial disease, ameliorating AWI abnormalities, and improving neurological outcomes is compelling and requires further investigation. 31 Importantly, all children with enhancement on AWI and anterior circulation ischemic infarction had abnormal vascular imaging. The 1 child with normal vascular imaging and AWI enhancement had ischemic infarction involving the posterior circulation. As such, we infer that AWI may be a useful adjunct of diagnostic utility specifically in children with AIS who already have abnormalities on conventional vascular imaging. Little has been reported in regard to AWI findings within the posterior circulation vessels, and consequently, considerable gaps in knowledge remain. 19, 21 There was no significant difference in stroke severity as measured by pediatric stroke outcome measure between the AWI enhancement groups. Lastly, we noticed a statistical trend toward significance in age differences between children with enhancement and those not displaying any enhancement on AWI, with the latter group being of younger age (median, 11.5 versus 6 years; P=0.186). Most likely, our study was not sufficiently powered to detect statistically significant differences between these 2 groups. 
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Nevertheless, this might suggest that either older children are more likely to experience AWI abnormalities or AWI could be technically more challenging to undertake in younger children taking into consideration the relatively long sequence time required to successfully complete these studies.
Mechanisms of Arterial Wall Enhancement
The phenomenon of arterial wall enhancement in contrastenhanced MRI is intriguing but remains poorly understood. In contrast-enhanced studies, some degree of symmetrical, linear perivascular enhancement is normally expected along extracranial and juxta-skull base segments of medium and large arteries but not within the circle of Willis. However, the mechanism of entry of contrast material (gadolinium) into the layers of diseased arterial walls remains unknown. Hypotheses include eccentric mechanical endothelial disruption as seen in histopathologic studies of intracranial carotid artery dissection 7 or concentric inflammatory endothelial disruption as seen in central nervous system vasculitis. 18 Data regarding the presence and role of vasa vasorum in intracranial vessel wall enhancement and vascular disease at all ages is controversial and extremely limited in children. 32, 33 Lastly, whether the presence of enhancement means active arterial wall disease and is a risk for disease recurrence and whether there is an agespecific effect of maturation on AWI findings is unknown.
34
Limitations and Future Directions
In an effort to apply an adapted AWI protocol to a pediatric population, we elected to only conduct AWI studies when study neuroradiologist (M.S.) was available. This approach allowed more standardized application of AWI. Hence, the limitations of our study include the small sample size and lack of consistent follow-up AWI studies on all participants over the study period. The use of gadolinium is a barrier to routine implementation of AWI in children with AIS given the current concerns regarding its safety. 35, 36 However, the use of contrast is still indicated and appropriate in children in the work-up for vasculitis. 37, 38 Caution needs to be exercised in the interpretation of vessel wall findings given the recognized mimics, such as flow-related or periarterial venous enhancement. Other artifacts that need to be considered when interpreting AWI include phase wrapping, pulsation calcification, and slowflow artifact, which commonly occurs in the sphenoparietal sinus and mimics middle cerebral artery wall enhancement. Hence, comparison with the MRA and confirmation of any suspected enhancement in at least 2 planes is essential.
Performing multisequence AWI added 10 to 30 minutes of scan time in our patients. This added time has to be taken into consideration for general anesthesia and factored in for awake patients who are unable to cooperate, leading to increased motion artifact and challenging interpretation. Although not the objective of this study, it would be pertinent to examine the quality of AWI studies in children and examine artifacts that obstruct interpretation. In this regard, 3-dimensional AWI sequences have recently become the standard in adult neuroradiological practice. To the best of our knowledge, these sequences have not yet been standardized or studied in children.
Conclusions
Our pilot study highlights the feasibility of conducting AWI studies in children presenting with AIS. Specific etiologic associations with patterns of AWI enhancement were not clearly identified in our study. However, we propose that AWI represents a promising technique that should be considered in all children presenting with acute AIS with abnormal cerebral vascular findings on standard imaging.
Well-powered prospective and systematic study designs that include populations of nonarteriopathic causes of AIS and healthy controls would inform future disease-targeted management, prognostication, and potentially influence outcome.
